Company

Company Team
Products

Stroke ILD Cancer

e-Stroke e-ASPECTS e-CTA e-CTP
Research & Trials
Resources

Resources News Support

Resources New Results from Mayo Clinic Provide Further Validation of e-ASPECTS Brainomix COVID-19 Webinar Future Healthcare Journal Kral et al (April 2020) Desai et al (April 2020) TRUST-CT Neuhaus et al 2019 Sundaram et al 2019 Reflections on ESO-WSO Webinar Grunwald et al 2019 Web Browser User Interface Brainomix Masterclass: NCCT & ASPECTS Brainomix Masterclass: CTA & Collaterals Brainomix Masterclass: CT Perfusion RESILIENT Trial NCIMI Podcast Oxford AHSN Newsletter New Mayo Clinic Study Validates e-ASPECTS as Accurate Stroke Assessment Tool Upcoming Webinar REGISTER for New Webinar: Optimizing the Role of AI in Healthcare Systems Meet Margaret 1-Year Reflection on NHSX AI in Health & Care Award Kiruba Study (Oct 2021)

News Automated stroke test from Oxford to save lives and costs Brainomix wins award to develop life-saving Oxford stroke software New office move Brainomix to present at BioTrinity 2014 Brainomix at World Stroke Congress 2014 Brainomix launches revolutionary e-ASPECTS software designed to improve outcomes for stroke patients First clinical installations of e-ASPECTS Brainomix receives funding to develop clinical decision-making software for stroke patients Brainomix shortlisted for TechCities Award Brainomix at Innovate 2015 event Brainomix at Medica 2015 Brainomix presented in Barclays and BGF Entrepreneurs Index UK Stroke Forum 2015 Brainomix announces a new release for its e-ASPECTS software (v4.8) Patient selection webinar now online Brainomix at ANIM 2016 Brainomix at ECR 2016 International Journal of Stroke publication Brainomix at ESOC 2016 Journal of Cerebrovascular Diseases publication CT Imaging in Acute Stroke Brainomix at neuroRAD 2016 Conference Brainomix Completes a £1,5 Million Investment Round International Journal of Stroke Publication 2016 Brainomix Announces a New Release for its e-ASPECTS software (v6) Brainomix at ANIM 2017 Brainomix joins forces with Boehringer Ingelheim to help save stroke victims Brainomix at ESOC 2017 American Journal of Neuroradiology Publication e-ASPECTS in Thrombectomy Trial in Brazil Brainomix at WFITN 2017 Budapest Brainomix Announces New Software Release e-ASPECTS 7.0 Brainomix Secures £7m ($9.8m) Investment to Tackle Stroke with AI Brainomix Announces CE Mark Certification for New e-CTA Software Brainomix & Olea Medical Join Forces to Revolutionize Stroke Imaging New Study: e-ASPECTS Predicts Patient Outcome and Risk of Bleeding in Acute Stroke Brainomix Partners with Oxford University in UK Government-Funded £17.5 Million Artificial Intelligence Programme Angels Initiative Wins Prestigious 2018 EFPIA Health Collaboration Award for Improving Stroke Care Study Shows e-ASPECTS May Be Sufficient for Selection of Late-Time Window Thrombectomy Patients Brainomix Listed as Finalist for “Best New Radiology Software” for Its e-CTA Stroke Imaging Solution New Study Highlights Clinical Value of Brainomix's e-ASPECTS Software for Stroke Patients Brainomix & Angels Initiative Releases the Angels WOW CT Training Tool New ESO Guidelines on Mechanical Thrombectomy Brainomix to Attend European Stroke Organisation Conference (ESOC) 2019 in Milan New Study: Brainomix Stroke Imaging Solution Improves Consistency of Image Interpretation for Doctors Brainomix Software Transforms Stroke Care in Braunschweig Brainomix Software Used to Select Patients in Ground-Breaking Brazilian Stroke Trial Brainomix Participates in NHS Expo with Boehringer Ingelheim to Showcase Transformative AI Portfolio for Stroke Brainomix Featured in BBC Technology Segment Focused on AI in Healthcare New Study: Using Simple Brain Scans Brainomix AI Software Can Generate Critical Information for the Treatment of Stroke Patients Brainomix Joins Global Stroke Community to Mark World Stroke Day 2019 New Results: Brainomix Software Shown to Improve Stroke Treatment Rates at Budapest University Hospital Brainomix Announces the Launch of its New e-Stroke Suite 9.0 e-Stroke Suite Launched Across Slovakian Stroke Network Sana Klinik Lübeck Incorporates e-Stroke Suite Into Stroke Service e-Stroke Mobile App Helps Royal Berkshire Stroke Team Manage Service During COVID-19 Crisis New e-Stroke Mobile App: Enabling Fast, Remote Access to Key Results e-Stroke Suite Goes Live at Newcastle Upon Tyne Hospitals Trust A Mid-Year Update from Brainomix Expansion of e-Stroke Suite Across Thames Valley Continues with Deployment at Buckinghamshire Healthcare NHS Trust University Hospital Milton Keynes Incorporates e-Stroke Suite into their Stroke Practice Brainomix Awarded Prestigious AI Grant to Demonstrate Impact in NHS Brainomix Achieves Breakthrough in Stroke Imaging with New Software Release ESO-WSO 2020 Virtual Conference OSIC Christmas 2020 Message Emory Stroke Study Brainomix Announces Partnership with Stryker Neurovascular Brainomix Announces Appointment of New Chairperson and Expanded Board Brainomix Selected to Present at Premier Tech Investor Events e-Stroke Transforms Lübeck Stroke Service Brainomix’s e-Stroke Platform Goes Live at North Tees & Hartlepool NHS Foundation Trust Brainomix’s e-Stroke Software Goes Live Across the University Hospitals Sussex NHS Foundation Trust BBC News Segment on e-Stroke at RBH East Sussex Go Live Dartford and Gravesham Barts Investment Round e-Stroke 11 BI Lung Cancer Project ILD Biomarker Athens Euroclinic Lecce New appointments CRO CFO
Careers
Contact

Demo

Search our Website

Enter text in the seach box above

Our Partners

Contact Details

UK HEAD OFFICE:
Suites 11-14,
Suffolk House
263 Banbury Road,
Oxford
OX2 7HN, England

BRAINOMIX EUROPE:
Suite 10380
26/27 Upper Pembroke Street
Dublin 2
D02 X361
Ireland

BRAINOMIX USA INC.
Correspondence address:
The Suites Collection,101 W. Grand, Suite 200, Chicago, Illinois 60654

Registered address:
Corporation Trust Center, 1209 Orange Street, Wilmington, DE 19801

Brainomix USA Inc. is a company registered in Delaware USA
+44 (0) 1865 582730
+44 (0) 1865 582752
info@brainomix.com

Latest News

All News
Events
In the Press
Case studies
Software releases
Recognitions

Media Kit

Find here our current information and assets for use in press publications and online articles.

If you would like any more information concerning Brainomix contact: info@brainomix.com

Delighted to be a Founder Member of @OSICild – Read the Q&A session with Dr George Harston, Chief Medical & Innovation Officer. Find out about Braimomix’s new #AI-powered #eILD solution here: https://t.co/4Y1FTqau9M https://t.co/UDFHyAo8ex

Brainomix, e-ASPECTS, e-CTA and e-CTP are registered trade marks of Brainomix Ltd in the UK. The Brainomix logo is a registered trademark.

Privacy Statement (UK) |Privacy Statement (EU)